Glycine From China; Determination, 9223 [2017-02340]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 22 / Friday, February 3, 2017 / Notices
By order of the Commission.
Issued: January 30, 2017.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2017–02276 Filed 2–2–17; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–1306 (Final)]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Determination
On the basis of the record 1 developed
in the subject investigation, the United
States International Trade Commission
(‘‘Commission’’) determines, pursuant
to section 735(b) of the Tariff Act of
1930 (19 U.S.C. 1673d(b)) (‘‘the Act’’),
that an industry in the United States is
materially injured by reason of imports
of large residential washers from China,
provided for in subheading 8450.20.00
of the Harmonized Tariff Schedule of
the United States, that have been found
by the Department of Commerce
(‘‘Commerce’’) to be sold in the United
States at less than fair value (‘‘LTFV’’).
Background
The Commission instituted this
investigation effective December 16,
2015, following receipt of a petition
filed with the Commission and
Commerce by Whirlpool Corporation,
Benton Harbor, Michigan. The
Commission scheduled the final phase
of the investigation following
notification of a preliminary
determination by Commerce that
imports of large residential washers
from China were being sold at LTFV
within the meaning of section 733(b) of
the Act (19 U.S.C. 1673b(b)). Notice of
the scheduling of the final phase of the
Commission’s investigation and of a
public hearing to be held in connection
therewith was given by posting copies
of the notice in the Office of the
Secretary, U.S. International Trade
Commission, Washington, DC, and by
publishing the notice in the Federal
Register of August 18, 2016 (81 FR
55231). The hearing was held in
Washington, DC, on December 7, 2016,
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
Jkt 241001
Issued: January 31, 2017.
Katherine M. Hiner,
Acting Supervisory Attorney.
On October 3, 2016, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Richard W. Walker,
M.D. (Registrant), of League City, Texas.
The Show Cause Order proposed the
revocation of his DEA Certificate of
Registration No. AW2558750, on the
ground that he does not have authority
to dispense controlled substances in
Texas, the State in which he is
registered with the Agency. Order to
Show Cause, at 1 (citing 21 U.S.C. 823(f)
and 824(a)(3)).
With respect to the Agency’s
jurisdiction, the Show Cause Order
alleged that Registrant is the holder of
Registration No. AW2558750, pursuant
to which he is authorized to dispense
controlled substances in schedules II
through V as a practitioner, at the
registered address of 4604 Hispania
View Drive, League City, Texas. Id. The
Order also alleges that Registrant’s
registration does not expire until May
31, 2017. Id.
As ground for the proposed action,
the Show Cause Order alleged that
‘‘[t]he Texas Medical Board issued an
order, effective June 10, 2016, which
accepted [the] surrender of [his]
authority to practice medicine.’’ Id. The
Order thus asserted that as a
consequence of the Board’s action,
Registrant is without authority to
dispense controlled substances in
Texas, the State in which he is
registered, and thus, ‘‘DEA must
revoke’’ his Registration. Id. at 1 (citing
21 U.S.C. 802(21), 823(f)(1) and
824(a)(3)).
The Show Cause Order notified
Registrant of his right to request a
hearing on the allegations or to submit
a written statement in lieu of a hearing,
the procedure for electing either option,
and the consequence of failing to elect
either option. Id. at 2 (citing 21 CFR
1301.43).
The Show Cause Order also notified
Registrant of his right to submit a
corrective action plan. Id. at 2–3 (citing
21 U.S.C. 824(c)(2)(C)).
[FR Doc. 2017–02245 Filed 2–2–17; 8:45 am]
Large Residential Washers From China
17:26 Feb 02, 2017
and all persons who requested the
opportunity were permitted to appear in
person or by counsel.
The Commission made this
determination pursuant to section
735(b) of the Act (19 U.S.C. 1673d(b)).
It completed and filed its determination
in this investigation on January 30,
2017. The views of the Commission are
contained in USITC Publication 4666
(January 2017), entitled Large
Residential Washers from China:
Investigation No. 731–TA–1306 (Final).
By order of the Commission.
Issued: January 30, 2017.
Lisa R. Barton,
Secretary to the Commission.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
VerDate Sep<11>2014
9223
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–718 (Fourth
Review)]
Glycine From China; Determination
On the basis of the record 1 developed
in the subject five-year review, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
antidumping duty order on glycine from
China would be likely to lead to
continuation or recurrence of material
injury to an industry in the United
States within a reasonably foreseeable
time.
Background
The Commission, pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)),
instituted this review on August 1, 2016
(81 FR 50547) and determined on
November 4, 2016 that it would conduct
an expedited review (81 FR 87589,
December 5, 2016).
The Commission made this
determination pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determination in
this review on January 31, 2017. The
views of the Commission are contained
in USITC Publication 4667 (January
2017), entitled Glycine From China:
Investigation No. 731–TA–718 (Fourth
Review).
By order of the Commission.
1 The record is defined in sec. 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
[FR Doc. 2017–02340 Filed 2–2–17; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Richard W. Walker, Jr., M.D.; Decision
and Order
E:\FR\FM\03FEN1.SGM
03FEN1
]]>Agencies
[Federal Register Volume 82, Number 22 (Friday, February 3, 2017)]
[Notices]
[Page 9223]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02340]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 731-TA-718 (Fourth Review)]
Glycine From China; Determination
On the basis of the record \1\ developed in the subject five-year
review, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that revocation of the antidumping duty order on glycine from
China would be likely to lead to continuation or recurrence of material
injury to an industry in the United States within a reasonably
foreseeable time.
---------------------------------------------------------------------------
\1\ The record is defined in sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------
Background
The Commission, pursuant to section 751(c) of the Act (19 U.S.C.
1675(c)), instituted this review on August 1, 2016 (81 FR 50547) and
determined on November 4, 2016 that it would conduct an expedited
review (81 FR 87589, December 5, 2016).
The Commission made this determination pursuant to section 751(c)
of the Act (19 U.S.C. 1675(c)). It completed and filed its
determination in this review on January 31, 2017. The views of the
Commission are contained in USITC Publication 4667 (January 2017),
entitled Glycine From China: Investigation No. 731-TA-718 (Fourth
Review).
By order of the Commission.
Issued: January 31, 2017.
Katherine M. Hiner,
Acting Supervisory Attorney.
[FR Doc. 2017-02340 Filed 2-2-17; 8:45 am]
BILLING CODE 7020-02-P
